Twist Bioscience Corp financial data

Symbol
TWST on Nasdaq
Location
South San Francisco, CA
Fiscal year end
30 September
Latest financial report
10-K - Q3 2025 - 17 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 420% % -21%
Quick Ratio 31% % -26%
Debt-to-equity 35% % 28%
Return On Equity -17% % 57%
Return On Assets -12% % 60%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 61,148,026 shares 3%
Common Stock, Shares, Outstanding 60,631,000 shares 3%
Entity Public Float $2,320,000,000 USD 21%
Common Stock, Value, Issued $0 USD
Weighted Average Number of Shares Outstanding, Basic 59,808,000 shares 3.1%
Weighted Average Number of Shares Outstanding, Diluted 59,808,000 shares 3.1%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue $185,570,000 USD 3.3%
Research and Development Expense $80,285,000 USD -12%
Costs and Expenses $512,831,000 USD -3.9%
Operating Income (Loss) $136,259,000 USD 38%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $76,951,000 USD 63%
Income Tax Expense (Benefit) $719,000 USD 28%
Net Income (Loss) Attributable to Parent $77,670,000 USD 63%
Earnings Per Share, Basic -1 USD/shares 64%
Earnings Per Share, Diluted -1 USD/shares 64%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $183,049,000 USD -19%
Cash, Cash Equivalents, and Short-term Investments $289,400,000 USD -20%
Accounts Receivable, after Allowance for Credit Loss, Current $57,019,000 USD 63%
Inventory, Net $28,309,000 USD 18%
Assets, Current $332,966,000 USD -4%
Property, Plant and Equipment, Net $102,283,000 USD -0.23%
Operating Lease, Right-of-Use Asset $49,377,000 USD -16%
Goodwill $82,195,000 USD -4.2%
Other Assets, Noncurrent $4,902,000 USD 213%
Assets $641,861,000 USD 4.5%
Accounts Payable, Current $11,094,000 USD 581%
Employee-related Liabilities, Current $31,288,000 USD -7%
Accrued Liabilities, Current $23,053,000 USD 53%
Liabilities, Current $91,406,000 USD 29%
Operating Lease, Liability, Noncurrent $61,750,000 USD -12%
Other Liabilities, Noncurrent $747,000 USD 84%
Liabilities $168,903,000 USD 19%
Accumulated Other Comprehensive Income (Loss), Net of Tax $627,000 USD -20%
Retained Earnings (Accumulated Deficit) $1,319,578,000 USD -6.3%
Stockholders' Equity Attributable to Parent $472,958,000 USD 0.06%
Liabilities and Equity $641,861,000 USD 4.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $21,428,000 USD 6.7%
Net Cash Provided by (Used in) Financing Activities $17,944,000 USD
Net Cash Provided by (Used in) Investing Activities $1,536,000 USD -137%
Common Stock, Shares Authorized 200,000,000 shares 100%
Common Stock, Shares, Issued 60,631,000 shares 3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $5,073,000 USD 75%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $185,425,000 USD -19%
Deferred Tax Assets, Valuation Allowance $383,378,000 USD 6.3%
Deferred Tax Assets, Gross $398,793,000 USD 5.3%
Operating Lease, Liability $75,572,000 USD -11%
Depreciation $23,800,000 USD -13%
Payments to Acquire Property, Plant, and Equipment $2,268,000 USD 51%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $77,775,000 USD 63%
Lessee, Operating Lease, Liability, to be Paid $118,937,000 USD -11%
Property, Plant and Equipment, Gross $197,277,000 USD 11%
Operating Lease, Liability, Current $13,822,000 USD -6.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two $8,450,000 USD -39%
Lessee, Operating Lease, Liability, to be Paid, Year One $13,963,000 USD -5.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $43,365,000 USD -11%
Lessee, Operating Lease, Liability, to be Paid, Year Three $8,510,000 USD 1.7%
Deferred Tax Assets, Operating Loss Carryforwards $232,380,000 USD 2.4%
Unrecognized Tax Benefits $25,288,000 USD 13%
Lessee, Operating Lease, Liability, to be Paid, Year Four $6,609,000 USD -22%
Operating Lease, Payments $14,707,000 USD 0.02%
Additional Paid in Capital $1,793,163,000 USD 4.6%
Amortization of Intangible Assets $1,100,000 USD -73%
Depreciation, Depletion and Amortization $6,380,000 USD -22%
Deferred Tax Assets, Net of Valuation Allowance $15,415,000 USD -16%
Share-based Payment Arrangement, Expense $64,459,000 USD 27%
Interest Expense $2,000 USD -93%